UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

Blood, 2000-09, Vol.96 (6), p.2062-2068

2000

Volltextzugriff (PDF)

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

Journal of clinical oncology, 1997-05, Vol.15 (5), p.1870-1879

1997

Volltextzugriff (PDF)

Practical considerations in the use of tacrolimus for allogeneic marrow transplantation

Bone marrow transplantation (Basingstoke), 1999-11, Vol.24 (10), p.1053-1056

1999

Volltextzugriff (PDF)

Modification of the Bu Cy myeloablative regimen using daily parenteral busulfan: reduced toxicity without the need for pharmacokinetic monitoring

Bone marrow transplantation (Basingstoke), 2005-04, Vol.35 (8), p.747-754

2005

Volltextzugriff (PDF)

A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma

Blood, 1996-08, Vol.88 (4), p.1188-1197

1996

Volltextzugriff (PDF)

FK506 in Combination With Methotrexate for the Prevention of Graft-Versus-Host Disease After Marrow Transplantation From Matched Unrelated Donors

Blood, 1996-11, Vol.88 (9), p.3634-3641

1996

Volltextzugriff (PDF)

Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer

JAMA : the journal of the American Medical Association, 1999-10, Vol.282 (14), p.1335

1999

Volltextzugriff (PDF)

Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation : apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression

Bone marrow transplantation (Basingstoke), 1992-10, Vol.10 (4), p.391-395

1992

Volltextzugriff (PDF)

High-Dose Etoposide, Cyclophosphamide, and Total Body Irradiation With Allogeneic Bone Marrow Transplantation for Patients With Acute Myeloid Leukemia in Untreated First Relapse: A Study by the North American Marrow Transplant Group

Blood, 1995-03, Vol.85 (5), p.1391-1395

1995

Volltextzugriff (PDF)

High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results

Journal of clinical oncology, 1989-09, Vol.7 (9), p.1260-1267

1989

Volltextzugriff (PDF)

High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group

Annals of internal medicine, 1993-06, Vol.118 (12), p.937

1993

Volltextzugriff (PDF)

Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation

Bone marrow transplantation (Basingstoke), 1998-03, Vol.21 (6), p.627-628

1998

Volltextzugriff (PDF)

Donor-Derived Long-Term Multilineage Hematopoiesis in a Liver-Transplant Recipient

The New England journal of medicine, 1993-03, Vol.328 (11), p.762-765

1993

Volltextzugriff (PDF)

Biological Effects of Recombinant Human Granulocyte Colony-Stimulating Factor in Patients With Untreated Acute Myeloid Leukemia

Blood, 1996-02, Vol.87 (4), p.1484-1494

1996

Volltextzugriff (PDF)

Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients

Bone marrow transplantation (Basingstoke), 1997-07, Vol.20 (1), p.49-51

1997

Volltextzugriff (PDF)

Transfusion of donor buffy coat cells in the treatment of persistent or recurrent malignancy after allogeneic bone marrow transplantation

Transfusion (Philadelphia, Pa.), 1995-11, Vol.35 (11), p.891-898

1995

Volltextzugriff (PDF)

Treatment of Progressive Hodgkin’s Disease With Intensive Chemoradiotherapy and Autologous Bone Marrow Transplantation

Blood, 1989-06, Vol.73 (8), p.2086-2092

1989

Volltextzugriff (PDF)

Allogeneic marrow transplantation for refractory Hodgkin's disease

Journal of clinical oncology, 1989-08, Vol.7 (8), p.1039-1045

1989

Volltextzugriff (PDF)

The Treatment of Progressive Non-Hodgkin's Lymphoma With Intensive Chemoradiotherapy and Autologous Marrow Transplantation

Blood, 1990-02, Vol.75 (4), p.831-838

1990

Volltextzugriff (PDF)

Graft-versus-host disease in a liver transplant recipient

Annals of internal medicine, 1992-03, Vol.116 (5), p.391-392

1992

Volltextzugriff (PDF)

Guidelines for systemic therapy of early stage breast cancer

Breast cancer research and treatment, 1997-05, Vol.43 (3), p.259-276

1997

Volltextzugriff (PDF)

Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma

Seminars in oncology, 1996-04, Vol.23 (2 Suppl 4), p.22-27

1996

Volltextzugriff (PDF)

Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma

Journal of clinical oncology, 1986-05, Vol.4 (5), p.639-645

1986

Volltextzugriff (PDF)

Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer

Bone marrow transplantation (Basingstoke), 1995-06, Vol.15 (6), p.929-933

1995

Volltextzugriff (PDF)

1 – 25 von 1.883

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.708)
Mit Volltextzugriff
(1.618)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.859)
Deutsch
(11)
Französisch
(7)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

Phase III study comparing methotrexate and tacrolimus (Prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation

Practical considerations in the use of tacrolimus for allogeneic marrow transplantation

Modification of the Bu Cy myeloablative regimen using daily parenteral busulfan: reduced toxicity without the need for pharmacokinetic monitoring

A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma

FK506 in Combination With Methotrexate for the Prevention of Graft-Versus-Host Disease After Marrow Transplantation From Matched Unrelated Donors

Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer

Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation : apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression

High-Dose Etoposide, Cyclophosphamide, and Total Body Irradiation With Allogeneic Bone Marrow Transplantation for Patients With Acute Myeloid Leukemia in Untreated First Relapse: A Study by the North American Marrow Transplant Group

High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and results

High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group

Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation

Donor-Derived Long-Term Multilineage Hematopoiesis in a Liver-Transplant Recipient

Biological Effects of Recombinant Human Granulocyte Colony-Stimulating Factor in Patients With Untreated Acute Myeloid Leukemia

Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients

Transfusion of donor buffy coat cells in the treatment of persistent or recurrent malignancy after allogeneic bone marrow transplantation

Treatment of Progressive Hodgkin’s Disease With Intensive Chemoradiotherapy and Autologous Bone Marrow Transplantation

Allogeneic marrow transplantation for refractory Hodgkin's disease

The Treatment of Progressive Non-Hodgkin's Lymphoma With Intensive Chemoradiotherapy and Autologous Marrow Transplantation

Graft-versus-host disease in a liver transplant recipient

Guidelines for systemic therapy of early stage breast cancer

Recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma

Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma

Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer

Suchergebnisse filtern